US · Healthcare

ATAI Life Sciences BV (ATAI)

Biotechnology

ATAI Life Sciences BV (ATAI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ATAI

P/E ratio

25.00

ATAI Life Sciences BV (ATAI) — FAQ

What is ATAI's P/E ratio?

The price-to-earnings (P/E) ratio for ATAI Life Sciences BV (ATAI) is 25.00 (data as of 2026-05-24).

Does ATAI Life Sciences BV pay a dividend?

Dividend yield is not available in the current snapshot for ATAI Life Sciences BV (ATAI). Check the MyAverix Finance app for the latest dividend data.

What sector is ATAI Life Sciences BV in?

ATAI Life Sciences BV (ATAI) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ATAI listed on?

ATAI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)